Open-Label, Single Dose, Parallel Group Pharmacokinetic Study of Ceftobiprole in Morbidly Obese and Non-Obese Patients.
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2016
At a glance
- Drugs Ceftobiprole medocaril (Primary)
- Indications Enterococcal infections; Methicillin-resistant Staphylococcus aureus infections; Pseudomonal infections; Streptococcal infections
- Focus Pharmacokinetics
- Sponsors Basilea Pharmaceutica
- 12 Apr 2016 Results presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases
- 27 Aug 2012 Company (Basilea Pharmaceutica) added as an association and lead centre as reported by ClinicalTrials.gov record.
- 24 Dec 2009 New trial record